Cargando…

The Role of Interleukin-8 in Lung Inflammation and Injury: Implications for the Management of COVID-19 and Hyperinflammatory Acute Respiratory Distress Syndrome

Severe Acute Respiratory Syndrome Coronavirus—2 (SARS CoV-2) has resulted in the global spread of Coronavirus Disease 2019 (COVID-19) and an increase in complications including Acute Respiratory Distress Syndrome (ARDS). Due to the lack of therapeutic options for Acute Respiratory Distress Syndrome,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cesta, Maria Candida, Zippoli, Mara, Marsiglia, Carolina, Gavioli, Elizabeth Marie, Mantelli, Flavio, Allegretti, Marcello, Balk, Robert A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790527/ https://www.ncbi.nlm.nih.gov/pubmed/35095519 http://dx.doi.org/10.3389/fphar.2021.808797

Ejemplares similares

Neutrophil activation and neutrophil extracellular traps (NETs) in COVID‐19 ARDS and immunothrombosis
por: Cesta, Maria Candida, et al.
Publicado: (2022)

The role of extracellular vesicles and interleukin-8 in regulating and mediating neutrophil-dependent cancer drug resistance
por: Zippoli, Mara, et al.
Publicado: (2022)

Repurposing the estrogen receptor modulator raloxifene to treat SARS-CoV-2 infection
por: Allegretti, Marcello, et al.
Publicado: (2021)

Emerging Approaches for the Management of Chemotherapy-Induced Peripheral Neuropathy (CIPN): Therapeutic Potential of the C5a/C5aR Axis
por: Spera, Maria C., et al.
Publicado: (2022)

Emerging Role of C5 Complement Pathway in Peripheral Neuropathies: Current Treatments and Future Perspectives
por: Giorgio, Cristina, et al.
Publicado: (2021)

Tamoxifen Twists Again: On and Off-Targets in Macrophages and Infections
por: Sfogliarini, Chiara, et al.
Publicado: (2022)

Intravitreal Administration of rhNGF Enhances Regenerative Processes in a Zebrafish Model of Retinal Degeneration
por: Cocchiaro, Pasquale, et al.
Publicado: (2022)

Allosteric Modulation of Chemoattractant Receptors
por: Allegretti, Marcello, et al.
Publicado: (2016)

Differential Effects of Nonsteroidal Anti-Inflammatory Drugs in an In Vitro Model of Human Leaky Gut
por: d’Angelo, Michele, et al.
Publicado: (2023)

A Novel Strategy to Mitigate the Hyperinflammatory Response to COVID-19 by Targeting Leukotrienes
por: Funk, Colin D., et al.
Publicado: (2020)

Decrease of the plasmatic endocan cleavage ratio is associated with the hyperinflammatory phenotype of acute respiratory distress syndrome
por: Gaudet, Alexandre, et al.
Publicado: (2019)

Cystic Fibrosis Inflammation: Hyperinflammatory, Hypoinflammatory, or Both?
por: Murphy, Sean V., et al.
Publicado: (2019)

Apolipoprotein-A-I for severe COVID-19-induced hyperinflammatory states: A prospective case study
por: Faguer, Stanislas, et al.
Publicado: (2022)

A phase 2 randomized, double-blinded, placebo-controlled, multicenter trial evaluating the efficacy and safety of raloxifene for patients with mild to moderate COVID-19
por: Nicastri, Emanuele, et al.
Publicado: (2022)

The Cholinergic Drug Pyridostigmine Alleviates Inflammation During LPS-Induced Acute Respiratory Distress Syndrome
por: Bricher Choque, Pamela Nithzi, et al.
Publicado: (2021)

Drugs for paediatric hyperinflammatory syndromes
por: Hon, Kam Lun, et al.
Publicado: (2022)

Interleukin 17A Participates in Renal Inflammation Associated to Experimental and Human Hypertension
por: Orejudo, Macarena, et al.
Publicado: (2019)

Ladarixin, an inhibitor of the interleukin‐8 receptors CXCR1 and CXCR2, in new‐onset type 1 diabetes: A multicentre, randomized, double‐blind, placebo‐controlled trial
por: Piemonti, Lorenzo, et al.
Publicado: (2022)

Characterization of raloxifene as a potential pharmacological agent against SARS-CoV-2 and its variants
por: Iaconis, Daniela, et al.
Publicado: (2022)

Haemophagocytic lymphohisticytosis—an underrecognized hyperinflammatory syndrome
por: Hutchinson, Matthew, et al.
Publicado: (2019)

Infection-Triggered Hyperinflammatory Syndromes in Children
por: Rossano, Martina, et al.
Publicado: (2022)

Aspirin Attenuates Hyperoxia-Induced Acute Respiratory Distress Syndrome (ARDS) by Suppressing Pulmonary Inflammation via the NF-κB Signaling Pathway
por: Tung, Yu-Tang, et al.
Publicado: (2022)

Liver Injury in Patients Hospitalized with Coronavirus Disease 2019 Correlates with Hyperinflammatory Response and Elevated Interleukin‐6
por: Da, Ben L., et al.
Publicado: (2020)

Targeting Neutrophils to Treat Acute Respiratory Distress Syndrome in Coronavirus Disease
por: Chiang, Chih-Chao, et al.
Publicado: (2020)

A Multicenter Phase 2 Randomized Controlled Study on the Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients with COVID-19 Pneumonia
por: Landoni, Giovanni, et al.
Publicado: (2022)

The Role of Pulmonary Surfactants in the Treatment of Acute Respiratory Distress Syndrome in COVID-19
por: Wang, Shengguang, et al.
Publicado: (2021)

Defining the scourge of COVID-19 hyperinflammatory syndrome
por: Cron, Randy Q, et al.
Publicado: (2020)

Therapeutic Strategies by Regulating Interleukin Family to Suppress Inflammation in Hypertrophic Scar and Keloid
por: Zhang, Dan, et al.
Publicado: (2021)

Effect of recombinant human nerve growth factor eye drops in patients with dry eye: a phase IIa, open label, multiple-dose study
por: Sacchetti, Marta, et al.
Publicado: (2020)

Inflammation-Independent Antinociceptive Effects of DF2755A, a CXCR1/2 Selective Inhibitor: A New Potential Therapeutic Treatment for Peripheral Neuropathy Associated to Non-Ulcerative Interstitial Cystitis/Bladder Pain Syndrome
por: Brandolini, Laura, et al.
Publicado: (2022)

A prospective investigation of interleukin-8 levels in pediatric acute respiratory failure and acute respiratory distress syndrome
por: Flori, Heidi, et al.
Publicado: (2019)

Combination of Ruxolitinib and Eculizumab for Treatment of Severe SARS-CoV-2-Related Acute Respiratory Distress Syndrome: A Controlled Study
por: Giudice, Valentina, et al.
Publicado: (2020)

Hyperinflammatory shock in children during COVID-19 pandemic
por: Riphagen, Shelley, et al.
Publicado: (2020)

Hyperinflammatory Response in COVID-19: A Systematic Review
por: Silva, Marcos Jessé Abrahão, et al.
Publicado: (2023)

The hyperinflammatory spectrum: from defects in cytotoxicity to cytokine control
por: Planas, Raquel, et al.
Publicado: (2023)

Drug‐resistant seizures associated with hyperinflammatory monocytes in FIRES
por: Howe, Charles L., et al.
Publicado: (2023)

Use of Cannabinoids to Treat Acute Respiratory Distress Syndrome and Cytokine Storm Associated with Coronavirus Disease-2019
por: Nagarkatti, Prakash, et al.
Publicado: (2020)

The Endocannabinoid Anandamide Attenuates Acute Respiratory Distress Syndrome by Downregulating miRNA that Target Inflammatory Pathways
por: Sultan, Muthanna, et al.
Publicado: (2021)

Network analysis-based strategy to investigate the protective effect of cepharanthine on rat acute respiratory distress syndrome
por: Chen, Chen, et al.
Publicado: (2022)

Effects of metformin on acute respiratory distress syndrome in preclinical studies: a systematic review and meta-analysis
por: Wang, Liu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gam8u58mpfiva5n6boga5da20t